AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNO
  4. [Form 4] CNO Financial Group, Inc. Insider Trading Activity

[Form 4] CNO Financial Group, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Jeanne L. Linnenbringer, Chief Operations Officer of CNO Financial Group (CNO), exercised stock options and sold common stock under a 10b5-1 plan. On 08/13/2025 she exercised 4,420 stock options with a $21.06 exercise price, acquiring 4,420 shares. Those shares and additional holdings were sold under a Rule 10b5-1 trading plan adopted May 5, 2025, with reported sales on 08/13/2025, 08/14/2025 and 08/15/2025 at weighted average prices of about $37.96, $37.9794 and $37.8495 respectively. Reported beneficial ownership fell from 45,583 shares after the option exercise to 30,844 shares after the sales. The filing notes vesting of the options (half vested 02/23/2019 and half 02/23/2020).

Jeanne L. Linnenbringer, Chief Operations Officer di CNO Financial Group (CNO), ha esercitato opzioni su azioni e venduto azioni ordinarie nell'ambito di un piano 10b5-1. Il 13/08/2025 ha esercitato 4.420 opzioni con prezzo di esercizio di $21.06, acquisendo 4.420 azioni. Queste azioni e altre partecipazioni sono state vendute secondo un piano di negoziazione Rule 10b5-1 adottato il 5 maggio 2025, con vendite segnalate il 13/08/2025, 14/08/2025 e 15/08/2025 a prezzi medi ponderati rispettivamente di circa $37.96, $37.9794 e $37.8495. La propriet脿 beneficiaria dichiarata 猫 passata da 45.583 azioni dopo l'esercizio delle opzioni a 30.844 azioni dopo le vendite. Il deposito segnala la maturazione delle opzioni (met脿 maturata il 23/02/2019 e met脿 il 23/02/2020).

Jeanne L. Linnenbringer, Chief Operations Officer de CNO Financial Group (CNO), ejerci贸 opciones sobre acciones y vendi贸 acciones ordinarias bajo un plan 10b5-1. El 13/08/2025 ejerci贸 4.420 opciones con precio de ejercicio de $21.06, adquiriendo 4.420 acciones. Esas acciones y otras participaciones se vendieron conforme a un plan de negociaci贸n Rule 10b5-1 adoptado el 5 de mayo de 2025, con ventas informadas el 13/08/2025, 14/08/2025 y 15/08/2025 a precios promedio ponderados de aproximadamente $37.96, $37.9794 y $37.8495, respectivamente. La propiedad beneficiosa declarada baj贸 de 45.583 acciones tras el ejercicio de las opciones a 30.844 acciones despu茅s de las ventas. La presentaci贸n indica la adquisici贸n de derechos de las opciones (la mitad adquirida el 23/02/2019 y la otra mitad el 23/02/2020).

Jeanne L. Linnenbringer, CNO Financial Group(CNO) 斓滉碃鞖挫榿毂呾瀯鞛�(COO)電� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橁碃 10b5-1 瓿勴殟鞐� 霐半澕 氤错喌欤茧ゼ 毵り皝頄堨姷雼堧嫟. 2025-08-13鞐� 頄夓偓臧�瓴� $21.06搿� 4,420欤� 攵勲焿鞚� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 4,420欤茧ゼ 旆摑頄堨姷雼堧嫟. 頃措嫻 欤检嫕瓿� 於旉皜 氤挫湢攵勳潃 2025-05-05鞐� 毂勴儩霅� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 毵り皝霅橃棃鞙茧┌, 毵り皝 鞁犼碃電� 2025-08-13, 2025-08-14, 2025-08-15鞐� 臧侁皝 臧�欷戫弶攴� 鞎� $37.96, $37.9794, $37.8495鞚� 臧�瓴╈溂搿� 鞚措（鞏挫鞀惦媹雼�. 氤搓碃霅� 鞙犾澋靻岇湢霟夓潃 鞓奠厴 頄夓偓 頉� 45,583欤检棎靹� 毵り皝 頉� 30,844欤茧 臧愳唽頄堨姷雼堧嫟. 靹滊鞐愲姅 鞓奠厴鞚� 氩犾姢韺呺弰 旮办灛霅橃柎 鞛堨溂氅�(鞝堧皹鞚� 2019-02-23, 雮橂ǜ歆� 鞝堧皹鞚� 2020-02-23鞐� 氩犾姢韸鸽惃)鞛呺媹雼�.

Jeanne L. Linnenbringer, Directrice des Op茅rations (COO) de CNO Financial Group (CNO), a exerc茅 des options sur actions et vendu des actions ordinaires dans le cadre d'un plan 10b5-1. Le 13/08/2025, elle a exerc茅 4 420 options au prix d'exercice de 21,06 $, acqu茅rant ainsi 4 420 actions. Ces actions et d'autres participations ont 茅t茅 vendues selon un plan de n茅gociation Rule 10b5-1 adopt茅 le 5 mai 2025, avec des ventes d茅clar茅es les 13/08/2025, 14/08/2025 et 15/08/2025 脿 des prix moyens pond茅r茅s d'environ 37,96 $, 37,9794 $ et 37,8495 $ respectivement. La propri茅t茅 b茅n茅ficiaire d茅clar茅e est pass茅e de 45 583 actions apr猫s l'exercice des options 脿 30 844 actions apr猫s les ventes. le dossier indique la p茅riode d'acquisition des options (la moiti茅 acquise le 23/02/2019 et l'autre moiti茅 le 23/02/2020).

Jeanne L. Linnenbringer, Chief Operations Officer der CNO Financial Group (CNO), hat Aktienoptionen ausge眉bt und Stammaktien im Rahmen eines 10b5-1-Plans verkauft. Am 13.08.2025 眉bte sie 4.420 Optionen zum Aus眉bungspreis von $21,06 aus und erwarb 4.420 Aktien. Diese Aktien und weitere Best盲nde wurden gem盲脽 einem am 5. Mai 2025 angenommenen Rule-10b5-1-Handelsplan ver盲u脽ert; gemeldete Verk盲ufe erfolgten am 13.08.2025, 14.08.2025 und 15.08.2025 zu gewichteten Durchschnittspreisen von etwa $37,96, $37,9794 bzw. $37,8495. Das gemeldete wirtschaftliche Eigentum sank von 45.583 Aktien nach Aus眉bung der Optionen auf 30.844 Aktien nach den Verk盲ufen. Die Einreichung vermerkt die Vesting-Termine der Optionen (die H盲lfte am 23.02.2019, die andere H盲lfte am 23.02.2020).

Positive
  • Use of a Rule 10b5-1 trading plan (adopted May 5, 2025) provides procedural transparency for the sales
  • Exercise of options at $21.06 followed by sales near $37.9 indicates capture of intrinsic value from vested options
Negative
  • Reported beneficial ownership declined materially from 45,583 shares after the exercise to 30,844 shares after the sales
  • Significant share sales over consecutive days (08/13/2025鈥�08/15/2025) reduced insider holdings, which may be viewed negatively by some investors

Insights

TL;DR: Routine option exercise followed by preplanned 10b5-1 sales; standard insider liquidity activity, not a regulatory red flag on its face.

The filing documents an option exercise at a $21.06 strike and subsequent sales executed under a 10b5-1 plan adopted May 5, 2025. Use of a 10b5-1 plan establishes an affirmative defense for the sales, reducing insider-trading concern assuming plan compliance. The disclosure of weighted average sale prices and the reduction in reported beneficial ownership provide transparency for investors and regulators.

TL;DR: Insider realized value by exercising low-strike options and selling at materially higher market prices; ownership declined materially.

The reporting person exercised 4,420 options with a $21.06 exercise price and sold shares at weighted averages near $37.9 per share across three days, implying a realized spread versus strike for those shares. The filing quantifies the sequential decrease in beneficial ownership from 45,583 to 30,844 shares. Transaction details and price ranges are disclosed, aiding assessment of insider liquidity but not providing forward guidance on company operations.

Jeanne L. Linnenbringer, Chief Operations Officer di CNO Financial Group (CNO), ha esercitato opzioni su azioni e venduto azioni ordinarie nell'ambito di un piano 10b5-1. Il 13/08/2025 ha esercitato 4.420 opzioni con prezzo di esercizio di $21.06, acquisendo 4.420 azioni. Queste azioni e altre partecipazioni sono state vendute secondo un piano di negoziazione Rule 10b5-1 adottato il 5 maggio 2025, con vendite segnalate il 13/08/2025, 14/08/2025 e 15/08/2025 a prezzi medi ponderati rispettivamente di circa $37.96, $37.9794 e $37.8495. La propriet脿 beneficiaria dichiarata 猫 passata da 45.583 azioni dopo l'esercizio delle opzioni a 30.844 azioni dopo le vendite. Il deposito segnala la maturazione delle opzioni (met脿 maturata il 23/02/2019 e met脿 il 23/02/2020).

Jeanne L. Linnenbringer, Chief Operations Officer de CNO Financial Group (CNO), ejerci贸 opciones sobre acciones y vendi贸 acciones ordinarias bajo un plan 10b5-1. El 13/08/2025 ejerci贸 4.420 opciones con precio de ejercicio de $21.06, adquiriendo 4.420 acciones. Esas acciones y otras participaciones se vendieron conforme a un plan de negociaci贸n Rule 10b5-1 adoptado el 5 de mayo de 2025, con ventas informadas el 13/08/2025, 14/08/2025 y 15/08/2025 a precios promedio ponderados de aproximadamente $37.96, $37.9794 y $37.8495, respectivamente. La propiedad beneficiosa declarada baj贸 de 45.583 acciones tras el ejercicio de las opciones a 30.844 acciones despu茅s de las ventas. La presentaci贸n indica la adquisici贸n de derechos de las opciones (la mitad adquirida el 23/02/2019 y la otra mitad el 23/02/2020).

Jeanne L. Linnenbringer, CNO Financial Group(CNO) 斓滉碃鞖挫榿毂呾瀯鞛�(COO)電� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橁碃 10b5-1 瓿勴殟鞐� 霐半澕 氤错喌欤茧ゼ 毵り皝頄堨姷雼堧嫟. 2025-08-13鞐� 頄夓偓臧�瓴� $21.06搿� 4,420欤� 攵勲焿鞚� 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 4,420欤茧ゼ 旆摑頄堨姷雼堧嫟. 頃措嫻 欤检嫕瓿� 於旉皜 氤挫湢攵勳潃 2025-05-05鞐� 毂勴儩霅� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 毵り皝霅橃棃鞙茧┌, 毵り皝 鞁犼碃電� 2025-08-13, 2025-08-14, 2025-08-15鞐� 臧侁皝 臧�欷戫弶攴� 鞎� $37.96, $37.9794, $37.8495鞚� 臧�瓴╈溂搿� 鞚措（鞏挫鞀惦媹雼�. 氤搓碃霅� 鞙犾澋靻岇湢霟夓潃 鞓奠厴 頄夓偓 頉� 45,583欤检棎靹� 毵り皝 頉� 30,844欤茧 臧愳唽頄堨姷雼堧嫟. 靹滊鞐愲姅 鞓奠厴鞚� 氩犾姢韺呺弰 旮办灛霅橃柎 鞛堨溂氅�(鞝堧皹鞚� 2019-02-23, 雮橂ǜ歆� 鞝堧皹鞚� 2020-02-23鞐� 氩犾姢韸鸽惃)鞛呺媹雼�.

Jeanne L. Linnenbringer, Directrice des Op茅rations (COO) de CNO Financial Group (CNO), a exerc茅 des options sur actions et vendu des actions ordinaires dans le cadre d'un plan 10b5-1. Le 13/08/2025, elle a exerc茅 4 420 options au prix d'exercice de 21,06 $, acqu茅rant ainsi 4 420 actions. Ces actions et d'autres participations ont 茅t茅 vendues selon un plan de n茅gociation Rule 10b5-1 adopt茅 le 5 mai 2025, avec des ventes d茅clar茅es les 13/08/2025, 14/08/2025 et 15/08/2025 脿 des prix moyens pond茅r茅s d'environ 37,96 $, 37,9794 $ et 37,8495 $ respectivement. La propri茅t茅 b茅n茅ficiaire d茅clar茅e est pass茅e de 45 583 actions apr猫s l'exercice des options 脿 30 844 actions apr猫s les ventes. le dossier indique la p茅riode d'acquisition des options (la moiti茅 acquise le 23/02/2019 et l'autre moiti茅 le 23/02/2020).

Jeanne L. Linnenbringer, Chief Operations Officer der CNO Financial Group (CNO), hat Aktienoptionen ausge眉bt und Stammaktien im Rahmen eines 10b5-1-Plans verkauft. Am 13.08.2025 眉bte sie 4.420 Optionen zum Aus眉bungspreis von $21,06 aus und erwarb 4.420 Aktien. Diese Aktien und weitere Best盲nde wurden gem盲脽 einem am 5. Mai 2025 angenommenen Rule-10b5-1-Handelsplan ver盲u脽ert; gemeldete Verk盲ufe erfolgten am 13.08.2025, 14.08.2025 und 15.08.2025 zu gewichteten Durchschnittspreisen von etwa $37,96, $37,9794 bzw. $37,8495. Das gemeldete wirtschaftliche Eigentum sank von 45.583 Aktien nach Aus眉bung der Optionen auf 30.844 Aktien nach den Verk盲ufen. Die Einreichung vermerkt die Vesting-Termine der Optionen (die H盲lfte am 23.02.2019, die andere H盲lfte am 23.02.2020).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Linnenbringer Jeanne L.
(Last) (First) (Middle)
C/O CNO FINANCIAL GROUP, INC.
11299 ILLINOIS STREET, SUITE 200
(Street)
CARMEL IN 46032
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operations Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 M 4,420 A $21.06 45,583 D
Common Stock 08/13/2025 S 4,420(1) D $37.9599(2) 41,163 D
Common Stock 08/13/2025 S 2,000(1) D $37.9599(2) 39,163 D
Common Stock 08/14/2025 S 4,862(1) D $37.9794(3) 34,301 D
Common Stock 08/15/2025 S 3,457(1) D $37.8495(4) 30,844 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $21.06 08/13/2025 M 4,420 (5) 02/23/2027 Common Stock 4,420 $0 0 D
Explanation of Responses:
1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 5, 2025.
2. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.82 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
3. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.795 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
4. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.68 per share to $38.24 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
5. One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020.
Remarks:
Heidi M. Krings, Attorney-in-Fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transactions did Jeanne L. Linnenbringer report on Form 4 for CNO?

The filing reports a 4,420-share option exercise at a $21.06 strike on 08/13/2025 and subsequent sales on 08/13/2025, 08/14/2025 and 08/15/2025 under a 10b5-1 plan.

How many CNO shares does the reporting person own after these transactions?

The filing shows 30,844 shares beneficially owned following the reported transactions.

Were the sales part of a preplanned trading program?

Yes. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on May 5, 2025.

At what prices were the CNO shares sold?

The filing discloses weighted average sale prices: approx. $37.9599, $37.9794, and $37.8495 with individual sale prices ranging about $37.68 to $38.24 across transactions.

When did the reported stock options vest?

The filing notes the options vested in two halves: 02/23/2019 and 02/23/2020.
Stock CNO logo
Cno Finl Group Inc

NYSE:CNO

CNO Rankings

#1574 Ranked by Market Cap
#1672 Ranked by Dividends

CNO Latest News

Aug 19, 2025
CNO Financial Group to Host Investor Briefing on Wednesday, September 10, 2025
Aug 6, 2025
CNO Financial Group Declares $0.17 Quarterly Dividend
Jul 28, 2025
CNO Financial Group Reports Second Quarter 2025 Results
Jul 14, 2025
CNO Financial Group to Release Second Quarter Results on July 28, 2025
Jun 23, 2025
Washington National Launches Individual Term Life Insurance Product

CNO Latest SEC Filings

Aug 15, 2025
[Form 4] CNO Financial Group, Inc. Insider Trading Activity
Aug 15, 2025
[Form 4/A] CNO Financial Group, Inc. Amended Insider Trading Activity
Aug 15, 2025
[144] CNO Financial Group, Inc. SEC Filing
Aug 15, 2025
[144] CNO Financial Group, Inc. SEC Filing
Aug 14, 2025
[Form 4] CNO Financial Group, Inc. Insider Trading Activity

CNO Stock Data

3.65B
94.59M
2.22%
97.42%
1.73%
Insurance - Life
Accident & Health Insurance
United States
CARMEL